Olga S. Samoilova

Velikiy Novgorod, NGR, Russian Federation

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

High-Temperature Oxidation Resistance of Fe-Free AlCoCrNiNb0.2 and AlCoCr0.5NiNb0.2 High-Entropy Alloys.

High-Temperature Oxidation Resistance of Fe-Free AlCoCrNiNb0.2 and AlCoCr0.5NiNb0.2 High-Entropy Alloys.

Journal: Materials (Basel, Switzerland)
Published: June 23, 2025

Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study.

Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study.

Journal: Med (New York, N.Y.)
Published: April 16, 2025

Corrosion Resistance of Al0.5CoCrFeNiCuxAgy (x = 0.25, 0.5; y = 0, 0.1) High-Entropy Alloys in 0.5M H2SO4 Solution.

Corrosion Resistance of Al0.5CoCrFeNiCuxAgy (x = 0.25, 0.5; y = 0, 0.1) High-Entropy Alloys in 0.5M H2SO4 Solution.

Journal: Materials (Basel, Switzerland)
Published: April 18, 2023

Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study.

Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study.

Journal: The Lancet. Haematology
Published: November 24, 2022

Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.

Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.

Journal: Leukemia
Published: November 24, 2022

Al0.25CoCrFeNiV High Entropy Alloy Coating Deposited by Laser Cladding on Stainless Steel.

Al0.25CoCrFeNiV High Entropy Alloy Coating Deposited by Laser Cladding on Stainless Steel.

Journal: Materials (Basel, Switzerland)
Published: September 17, 2022

Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.

Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.

Journal: EJHaem
Published: June 29, 2022

COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study.

COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study.

Journal: HemaSphere
Published: May 02, 2022

Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study.

Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study.

Journal: Clinical lymphoma, myeloma & leukemia
Published: June 07, 2021

High-Temperature Oxidation of High-Entropic Alloys: A Review.

High-Temperature Oxidation of High-Entropic Alloys: A Review.

Journal: Materials (Basel, Switzerland)
Published: April 14, 2021

Properties of WC-10%Co-4%Cr Detonation Spray Coating Deposited on the Al-4%Cu-1%Mg Alloy.

Properties of WC-10%Co-4%Cr Detonation Spray Coating Deposited on the Al-4%Cu-1%Mg Alloy.

Journal: Materials (Basel, Switzerland)
Published: February 09, 2021

Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

Journal: Leukemia & lymphoma
Published: August 09, 2020
Showing 1-12 of 32

Last Updated: 09/26/2026